Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price fell 15.4% during mid-day trading on Wednesday . The company traded as low as C$0.06 and last traded at C$0.06. 131,500 shares changed hands during mid-day trading, an increase of 68% from the average session volume of 78,329 shares. The stock had previously closed at C$0.07.
Sirona Biochem Stock Down 7.7 %
The firm has a fifty day simple moving average of C$0.06 and a 200 day simple moving average of C$0.07. The company has a debt-to-equity ratio of 219.21, a quick ratio of 2.41 and a current ratio of 0.34. The company has a market cap of C$15.41 million, a PE ratio of -6.00 and a beta of -0.03.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Recommended Stories
- Five stocks we like better than Sirona Biochem
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Short Selling – The Pros and Cons
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What is Short Interest? How to Use It
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
